Transplant Hepatology fellow at MedStar Georgetown. Views are my own.
Los Angeles, CA
Joined April 2010
- Tweets43
- Following144
- Followers193
- Likes83
Christopher Coe retweeted
📢Check out the winning #HepMadness summary by @drmuaazmasood on bridging the gaps in guideline directed care!
LNF clinical pearl content writer @SarahUttal won🥇for her bracket submission—winning a free @AASLDtweets post-grad course!
Join the fun of #HepMadness next fall!
Mind the Gap! Check out @drmuaazmasood summary of 4⃣ 🔑 articles about bridging gaps in guideline-directed hepatology care. How will you use these @HepCommJournal 📜 to improve outcomes in your own hepatology practice?🤔
#HepMadness #Livertwitter #MedEd
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
Happening in 6 minutes! Come support our fabulous trainees and see what LFN has to offer!
📢All trainees and #MedEd enthusiasts!
❓Where are you going to be at 11 am today?
📍Ballroom 6C for “The best of Liver Fellow Network”
Learn with us and support our fantastic content writers 👏👏👏
Christopher Coe retweeted
We are extending HepMadness deadline until tomorrow! Be sure to play and potentially win fantastic prizes! See below for how to play!⬇️
Today’s a great day to submit your #hepmadness bracket! Here’s how:
1) follow this link: tourneytopia.com/aasld/hepma…
2) sign up (takes 30 seconds)
3) fill out your bracket and get awesome summaries of the latest and greatest hep research from @HepCommJournal and @LTxJournal
Christopher Coe retweeted
Living donors & split🔪 livers are crucial for addressing the shortage of available livers for transplantation. Learn more in this post by @s_taranika summarizing 5⃣ 📜 in @LTxJournal
#HepMadness #livertwitter #GItwitter #MedEd
Fill out your bracket 👇
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
Should we start rx’ing statins stat? 💊
@crlopez92 breaks down 3 key articles in HepComm for us. See her post below, and let us know: did you pass out atorvastatin for your hepatology patients this Halloween?🎃
#Hepmadness #livertwitter #FOAMed #MedEd
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
🚨🚨GI/hep fellows studying for boards!🚨🚨🚨
⬇️76 hepatology practice questions now available thanks to @AASLDtweets & @LiverFellow
aasld.org/liver-fellow-netwo…
👏 👏👏Major kudos to fellow authors & faculty editor Matt Odenwald!
#livertwitter #gitwitter #meded
Today’s a great day to submit your #hepmadness bracket! Here’s how:
1) follow this link: tourneytopia.com/aasld/hepma…
2) sign up (takes 30 seconds)
3) fill out your bracket and get awesome summaries of the latest and greatest hep research from @HepCommJournal and @LTxJournal
Christopher Coe retweeted
You are invited to play HepMadness
Brought to you by @LiverFellow
Fill out a bracket: tourneytopia.com/aasld/hepma…
Pick your winners amongst the hottest topics in all of liverland and, maybe, win a prize
Inspired by work published in @LTxJournal and @HepCommJournal
Christopher Coe retweeted
🤖Rise of the machines!
Machines have undoubtedly transformed liver transplantation and can expand our donor pool, but can be associated with 📈 complications. Check out this great summary @sanad_dawod of 5️⃣ recent 📝!
#HepMadness #livertwitter #MedEd
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
Great job, Sanad! Check out this post on “rise of the machines” in @LTxJournal! Also, be sure to fill out your #HepMadness bracket!👇
tourneytopia.com/aasld/hepma…
#HepMadness is here! Check out my entry!
Had so much fun learning about the different available technologies that will allow us to expand access to transplant! @LTxJournal @AASLDtweets #livertwitter #GITwitter
Christopher Coe retweeted
Mind the Gap! Check out @drmuaazmasood summary of 4⃣ 🔑 articles about bridging gaps in guideline-directed hepatology care. How will you use these @HepCommJournal 📜 to improve outcomes in your own hepatology practice?🤔
#HepMadness #Livertwitter #MedEd
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
🏥The circle-based allocation system was designed to better comply with the Final Rule (🩺 urgency > 🌎 )...but has it? Dive into these 4⃣@LTxJournal 📜to explore ongoing inequities, benefits of standardization, and more! @AnjanaRajanMD #HepMadness #MedEd
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
Hmm...👨⚕️👩⚕️providers & patients aren’t 🗣️ about 🍷🍸enough, even though 🍺🍹 leads to progression of liver disease. 🤔Check out this evidence summary ✍️ by Mary McGrath on how this care gap ➡️ poor outcomes.
#HepMadness #livertwitter #MedEd
🗳️✅Bracket👇:
tourneytopia.com/aasld/hepma…
Christopher Coe retweeted
‼️#HepMadness is here‼️
What: NCAA-style bracket competition: @HepCommJournal vs. @LTxJournal
Who: You!
Where: Follow on #LiverTwitter/X, 🥇🥈🥉 to be announced at #TLM24
How: Read the posts ➕ fill out your bracket by 11/11, full instructions 👇
tourneytopia.com/aasld/hepma…
So grateful to @ArpanPatelMD for his mentorship and guidance! Proud to present our QI project: Pilot testing a novel AUD curriculum for GI Fellows at @UCLAGIHep
Christopher Coe retweeted
Development & Pilot Testing of a Novel Alcohol Use Disorder Training Program for GI Fellows
🙌Christopher L. Coe, MD (@CCoeMD)
👥 @_DavidLawrence7 @JBenhammouMD @TienDongMD @JulioMe74531224 @ponnivp @jasleensinghmd @LinChangMD @ArpanPatelMD et al
⏰#DDW2024 May 19, 12:30 pm
Welcome to the UCLA GI Fellowship family!
🙌Look who's joining #UCLAGI! We are thrilled & know you will thrive under the mentorship of @LinChangMD
🌟Preetha Iyengar
🌟Bryan Kim @bryan_jkim
🌟Sagar "Arnie" Shah @ArnieShahMD
🌟Brandon Smith @BrandonCSmithMD
🌟Ellen Spartz
🌟Farnoosh Vahedi
🌟Sigrid Young @SigridYoungMD
Christopher Coe retweeted
📢Terlipressin & CCM by POCUS
🌟CCM & its echo markers associated w ⬆️ risk of non-response to Terlipressin
🌟 CCM predicts mortality in HRS-AKI
🌟 Patients with CCM on Terlipressin may be at ⬆️risk of pulm edema
#CCM @HEP_Journal
@docMPK leading the way in POCUS in Cirrhosis
Continuing terli series and POCUS-
CCM & terli non-response predicts mortality @HEP_Journal
Congratulations @docMPK @manhalizzy Dr Kamal Kajal.
@AsraniSumeet @acv69cardenas @JuanAbraldes pubmed.ncbi.nlm.nih.gov/3797…
Christopher Coe retweeted
Great results from the first clinical trial testing NALTREXONE vs placebo in alcohol-related cirrhosis, today at #TLM23 :
🔸Naltrexone is well tolerated
🔸It favors abstinence
🔸It reduces by 50% new onset decompensation
@AASLDtweets #livertwitter #MedTwitter @ILBS_India
